Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Peter George joins Board of Ergomed as Non-Executive Director
Peter George joins Board of Ergomed as Non-Executive Director
He is currently Chief Executive of Clinigen
SGS makes key appointments at new California facility
SGS makes key appointments at new California facility
Carson, California plant is due to open in the third quarter 2014
Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer
Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer
Cox was formerly EVP and Chief Commercial Officer at the biopharmaceuticals company
Brookfield names Gerhard Baumann as Managing Director for Brookfield Germany
Brookfield names Gerhard Baumann as Managing Director for Brookfield Germany
Takes responsibility for the full line of Brookfield laboratory instruments
Pharmagen recruits Frederick Mundt as Senior Vice President of Sales
Pharmagen recruits Frederick Mundt as Senior Vice President of Sales
Has been in the industry for more than 20 years
Amgen appoints regulatory affairs and safety specialist
Amgen appoints regulatory affairs and safety specialist
Steven Galson gains a promotion
GenSight Biologics appoints Jean-Philippe Combal as Chief Operating Officer
GenSight Biologics appoints Jean-Philippe Combal as Chief Operating Officer
He brings extensive experience in ophthalmologic diseases to the French company
Sven Andreasson joins Novavax as SVP of Corporate Development
Sven Andreasson joins Novavax as SVP of Corporate Development
Formerly CEO of Isconova, which was acquired by Novavax last year
Midatech makes two appointments
Midatech makes two appointments
Strengthening the Board and senior management team
Astellas makes a promotion and a new appointment
Astellas makes a promotion and a new appointment
In Global Development and Global Medical Affairs
Kenneth Sommerville joins GW Pharmaceuticals as VP of Clinical Science
Kenneth Sommerville joins GW Pharmaceuticals as VP of Clinical Science
To support US medical affairs and regulatory activities related to epilepsy programmes
Sygnature Discovery hires Director of Business Development
Sygnature Discovery hires Director of Business Development
Dr Gerry Thomas joins the company
Juergen Hambrecht becomes Chairman of BASF Supervisory Board
Juergen Hambrecht becomes Chairman of BASF Supervisory Board
Succeeding Eggert Voscherau
Daniel Smith rejoins Cobra Biologics as Chief Scientific Officer
Daniel Smith rejoins Cobra Biologics as Chief Scientific Officer
After four years at the UK\'s HealthTech & Medicines KTN
Enterome appoints Alessandra Cervino as Head of Discovery
Enterome appoints Alessandra Cervino as Head of Discovery
Brings genetic and genomic biomarkers experience to the company
Sally Adams joins Scancell Holdings Board as Development Director
Sally Adams joins Scancell Holdings Board as Development Director
With 25 years of industry experience
Previous
1
…
128
129
130
131
(current)
132
133
134
…
216
Next
Trending Articles
Gerresheimer names new Chairman of the Supervisory Board
This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe
Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer
Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
Hovione appoints Stefan Doboczky as Chief Executive Officer
Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all